Hepatitis C virus infection and clinical outcome of kidney transplantation

Abstract

Abstract: Objective To study the influence of hepatitis C virus (HCV) infection on the clinical outcome of kidney transplan-tation. Methods The recipient/graft survival, the incidence of acute/chronic rejection and cause of death in 86 HCV-infected recipients of renal transplantation were compared with those in another 86 recipients without HCV infection. Results HCV-infected recipients had significantly shorter 5-year survival (74.4%) than those without HCV infection (87.2%, P<0.01). The 1-year (94.2%/90.7% vs 96.8%/96.0%) and 3-year recipient/graft survival rates (88.4%/79.1% vs 90.7%/87.2%), the incidence of acute/chronic rejection (31.3% vs 21.2%, and 12.5% vs 6.5%) and the 5-year graft survival (73.3%/81.4%) were comparable between the two groups (P>0.05). Hepatic disease was identified as the primary cause of mortality. Conclusions HCV infection may affect the long-term survival of the recipients with kidney transplantation, and therefore should be considered as a relative contraindication of kidney transplantation.

CLC Number:

YU Li-xin, WANG Zhi-peng, FU Shao-jie, WANG Yi-bin, DU Chu-fu, XU Jian, DENG Wen-feng. Hepatitis C virus infection and clinical outcome of kidney transplantation[J]. Journal of Southern Medical University, 2004, 24(06): 682-684.

References

[1] McCruden EA,Welch S,Batchelor B,et al.Hepatitis C virus infection detected by antibody tests and the polymetase chain reaction as a cause of liver dysfunction in renal transplant recipients[J].JMed Virol,1994,42(2):158-63.
[2] Brunson ME,LauJY,Davis GL,et al.Non-A,Non-B hepatitis and elevated serum aminotransferases in renal transplant patients [J].Transplantation,1993,56(7):1364-7.
[3] Roth D.Hepatitis C virus:the nephrologist’s view[J].AmJKidney Dis,1995,25(1):3-16.
[4] Mathuin P,Mouquet C,Poynard T,et al.Impact of hepatitis B and C virus on kidney transplantation outcome[J].Hepatology,1999,29(1):257-63.
[5] Roth D,Zucker K,Cirocco R,et al.The impact of hepatitis C virus infection on renal allograft recipients[J].Kidney Iht,1994,45(1):238-44.
[6] 夏穗生.临床移植学[M].杭州:浙江科学技术出版社,1991.137-42.
[7] 郑树森.肝脏移植[M].北京:人民卫生出版社,2001.112-3.
[8] Boletis J,Deliadetsima J,Psimenou E,et al.Liver biopsy is essential in anti-HCV (+) renal transplant patients irrespective of liver function tests and serology for HCV[J].Transplant Proc,1995,27(1):945-7.
[9] Sagnelli E,Piccinino F,Marzollo G,et al.Effect ofimmuno-suppressive therapy on HBsAg positive chronic active hepatitis in relation to presence and absence of HBsAg and anti-Hbe [J].Hepatology,1983,3(5):690-5.
[10] Jain AK,FungJJ.Hepatitis C virus and renal failure[J].Transplant Proc,2003,35(1):4168.
[11] Kramer P,ten Kate FW,Bijnen AB,et al.Recombinant leucocyte interferon A induces steroid-resistant acute vascular rejection episodes in renal transplant recipients [J].Lancet,1984,1 (8384):989-90.
[12] Dhar DK,Nagasue N,Kimoto T,et al.The salutary effect of FK506in isochemia reperfusion injury of the canine liver [J].Transplantation,1992,54(4):583-8.
[13] Francavilla A,Barone M,Todo S,et al.Augmentation of rat liver regeneration by FK506 compared with cyclosporin [J].Lancet,1989,2(8674):1248-9.
[14] 吴健,谢海洋,蒋国平,等.霉酚酸对乙型肝炎病毒作用的体外实验[J].中华器官移植杂志,2003,24(5):310-2.WuJ,Xie HY,Jiang GP,et al.The role of mycophenolate acid on HBV replicationin vitro[J].Chin Organ Transplant,2003,24(5):310-2.
[15] 邱实,刘龙,赵黎明,等.血清肝炎病毒标记物阳性或肝炎患者肾移植术后测定环孢素C2的意义[J].中华器官移植杂志,2003,24(1):26-7.Qiu S,Liu L,Zhao LM,et al.Neoral C2 predicting drug hepatic toxicity following renal transplantation in hepatitis patients[J].Chin J Organ Transplant,2003,24(1):26-7.